Skip to content

LHMi

Active
Private limited company·Activiteiten van tandartspraktijken· 5 yrs active
Kruitmolenstraat 50 ·1000 Brussel, Belgium
KBO/BCE: BE 0755.459.655
Watch Print / PDF
Age5 yrs
Staff (FTE)1

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of LHMi is 0.3% (very low). The 2024 annual accounts show equity of €301k and a net result of €86k. Equity is growing by ~40.4% per year across the filed fiscal years. Its solvency ranks better than 58% of 6569 sector peers (fiscal year 2024). The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 4 annual accounts.

Signals

2 signals · with evidence
Consistently profitable
Positive net result in the two most recent financial years (2023 and 2024).
View the result trend
Growing equity
Equity grew over 2022-2024. Profits are largely retained rather than distributed.
View the equity trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Trust signals

3 signals
More than 3 years active
Founded in 2020, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).

Administrative Flags

0 events
No administrative flags

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.3% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector Young company +Higher-failure-rate region +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€86k+42.4%
Working capital€-27+99.9%

Annual accounts & ratios

Source: NBB · 2024
Annual accounts filed on 16-06-2025 with the NBB · fiscal year 2024 · micro
€0€50k€100k€150kOperating result 2021: €96k€96kNet result 2021: €69k€69kOperating result 2022: €118k€118kNet result 2022: €82k€82kOperating result 2023: €92k€92kNet result 2023: €61k€61kOperating result 2024: €132k€132kNet result 2024: €86k€86k2021202220232024
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing Equity: growth of ~40.4%/year over 4 fiscal years, indicative, assuming unchanged policy.
€0€200k€400k€600k2025: €374k (€350k - €398k)2026: €448k (€424k - €472k)2027: €523k (€499k - €547k)2021: €74k2022: €154k2023: €215k2024: €301k2021202220232024202520262027
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (micro schema)
Metric This company Sector median Position in the sector
Solvency 72.8% 66.7%
better than 58% of 6569 sector peers
Net result €86k €46k
better than 72% of 6563 sector peers
Equity €301k €79k
better than 88% of 6569 sector peers
Gross operating margin €211k €78k
better than 86% of 6571 sector peers
Staff costs €37k €21k
higher than 68% of 1207 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
Solvency P58
2021: P31 · n=18282022: P23 · n=36622023: P36 · n=53262024: P58 · n=65692021 2024
Improving position over 2021-2024 · n=1828-6569
Net result P72
2021: P68 · n=18282022: P76 · n=36602023: P66 · n=53252024: P72 · n=65632021 2024
Stable position over 2021-2024 · n=1828-6563
Equity P88
2021: P58 · n=18282022: P80 · n=36622023: P84 · n=53282024: P88 · n=65692021 2024
Improving position over 2021-2024 · n=1828-6569
Gross operating margin P86
2021: P65 · n=18292022: P78 · n=36582023: P84 · n=53222024: P86 · n=65712021 2024
Improving position over 2021-2024 · n=1829-6571
Describes the position versus peers, not a forecast.
EBITDA
€170k
+30.2% +35% vs sector
Net profit
€86k
+42.4% +28% vs sector
Cash flow
€125k
+25.8% +13% vs sector
Total assets
€414k
-3.5% -3% vs sector
Equity
€301k
+40.1% +10% vs sector
Working capital
€-27
+99.9% far below sector median
Employees (FTE)
1
0.0% -71% vs sector
Staff costs
€37k
+7.9% -69% vs sector
Income taxes
€36k
+54.5% +2% vs sector
Dividends
€0
-100.0% -100% vs sector
Debt
€113k
-47.3% -15% vs sector
Debt ≤ 1y
€82k
-5.2% -29% vs sector
Debt > 1y
€27k
-78.9% +42% vs sector
Current ratio
1.00
+38.2% -63% vs sector
Quick ratio
0.75
+70.9% -72% vs sector
Solvency
72.8%
+45.2% +14% vs sector
Debt / equity
0.37
-62.4% -34% vs sector
ROE
28.6%
+1.6% -2% vs sector
ROA
20.8%
+47.6% +12% vs sector
Interest coverage
17.35
+11.3% -62% vs sector
Figures by fiscal year
Fiscal year2024
Revenue-
EBITDA€170k
Net profit€86k
Cash flow€125k
Staff costs€37k
Income taxes€36k
Dividends-
Total assets€414k
Equity€301k
Debt€113k
of which ≤ 1y€82k
of which > 1y€27k
Working capital€-27
Employees (FTE)1.0
Ratios (computed)
2024
Current ratio1.00
Quick ratio0.75
Working capital ratio0.0%
Solvency72.8%
Debt / equity0.37
Long-term debt ratio0.09
Interest coverage17.35
Gross margin-
Net margin-
ROA20.8%
ROE28.6%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2024
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2024
Balance sheet, Assets
TOTAL ASSETS 20/58€414k
Fixed assets 21/28€331k
Intangible fixed assets 21€72k
Tangible fixed assets 22/27€259k
Current assets 29/58€82k
Stocks & contracts in progress 3€20k
Amounts receivable within one year 40/41€1k
Cash & bank 54/58€52k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€414k
Equity 10/15€301k
Contributions / capital 10/11€5k
Reserves 13€293k
Accumulated profits (losses) 14€3k
Amounts payable 17/49€113k
Amounts payable after one year 17€27k
Amounts payable within one year 42/48€82k
Trade debts payable within one year 44€3k
Income statement
Gross operating margin 9900€211k
Operating result 9901€132k
Financial income 75€128
Financial charges 65€10k
Result before taxes 9903€122k
Income taxes 67/77€36k
Net result for the period 9904€86k
Result to be appropriated 9905€86k
You're seeing the latest fiscal year only. Unlock 3 prior years (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2024 · computed
76 / 100 Excellent
050100

Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.

See plans →
Computed by Checked from NBB filings and Belgian State Gazette signals. Indicative, not credit advice.

Structure & network

Locations & real estate

Establishment units

1 location
LHMi
Paul Emile Jansonstraat 3, 1000 BrusselActiviteiten van tandartspraktijken
since 20202.308.335.130
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels2
Ground area384 m²
Buildings2
Building footprint318 m²
Volume (LiDAR)5,394 m³
Tallest building22.3 m · ±6 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Brussels 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21807G0089/00K006 Brussels 319 m² 1 · 252 m² 22.3 m · 6 fl.
21811M2572/00B000 Brussels 65 m² 1 · 66 m² 14.4 m · 4 fl.
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Analysis

Snowflake analysis

financial profile on 5 axes
Health76Profitability100Solvency78Growth78Stability94
85 / 100

Exceptional profile, strong across almost every axis.

Health 76
Profitability 100
Solvency 78
Growth 78
Stability 94

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
AI-generated from Checked data; indicative, not legal or investment advice.

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Same sector, ranked by comparable size

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Tandartspraktijken86230Activiteiten van tandartspraktijken86230
Primary activity highlighted.
Names & trade names
Legal nameFR LHMi
Registered office
Kruitmolenstraat 50
1000 Brussel, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.